COVID-19 is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has caused several general occurrence cases, in Saudi Arabia and other Middle Eastern countries. The disease is characterized by a wide spectrum of clinical symptoms, including exhaustion, trouble breathing, cognitive impairment, and chest discomfort for several weeks to months following the infection. To contain the epidemic, every nation used multiple healthcare system strategies, including in the laboratory medicine. Saudi Arabia has developed many strategic policies and implemented scientific regulations to utilize laboratory medicine to control the pandemic. In this review, we have detailed the different aspects related to COVID-19 infections, the major challenges, and different strategies implemented by the Kingdom of Saudi Arabia to successfully contain the infections focused on laboratory expertise and new policy implementations in the specialty areas such as research and development, integration with public health strategies, implementation of advanced diagnostic technologies and operation of testing center.

COVID-19; laboratory medicine; Saudi Arabia; public health; pandemic

1. Adeli, K. (2020). Critical role of laboratory medicine in the global response to the COVID-19 pandemic. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1019–1020. https://doi.org/10.1515/cclm-2020-0742
2. Al Ammi, S., Mzahim, B., Alomari, H., et al. (2022). Reduction of MERS-CoV Transmission among Healthcare Workers and Patients in Saudi Arabian Healthcare Settings: A Scoping Review. The Journal of Medicine, Law and Public Health, 3(1), 159–191. https://doi.org/10.52609/jmlph.v3i1.63
3. Al Mutair, A., Alhumaid, S., Alhuqbani, W. N., et al. (2020). Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study. European Journal of Medical Research, 25(1). https://doi.org/10.1186/s40001-020-00462-x
4. Al Shehri, A. M. (2015). A lesson learned from Middle East respiratory syndrome (MERS) in Saudi Arabia. Medical Teacher, 37(sup1), S88–S93. https://doi.org/10.3109/0142159x.2015.1006610
5. Alanzi, T. M., Althumairi, A., Aljaffary, A., et al. (2021). Evaluation of the Mawid mobile healthcare application in delivering services during the COVID-19 pandemic in Saudi Arabia. International Health, 14(2), 142–151. https://doi.org/10.1093/inthealth/ihab018
6. Alassaf, N., Bah, S., Almulhim, F., et al. (2021). Evaluation of Official Healthcare Informatics Applications in Saudi Arabia and their Role in Addressing COVID-19 Pandemic. Healthcare Informatics Research, 27(3), 255–263. https://doi.org/10.4258/hir.2021.27.3.255
7. Alfadda, A. A., AlKhowaiter, M., Alotaibi, N., et al. (2021). Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparison. Journal of Infection and Public Health, 14(11), 1623–1629. https://doi.org/10.1016/j.jiph.2021.09.014
8. Algarni, A. D., Ben Hamed, A., Hamdi, M., et al. (2022). Mathematical COVID-19 model with vaccination: a case study in Saudi Arabia. PeerJ Computer Science, 8, e959. https://doi.org/10.7717/peerj-cs.959
9. Alghamdi, S. M., Alsulayyim, A. S., Alqahtani, J. S., et al. (2021). Digital Health Platforms in Saudi Arabia: Determinants from the COVID-19 Pandemic Experience. Healthcare, 9(11), 1517. https://doi.org/10.3390/healthcare9111517
10. Alharbi, A., Alzuwaed, J., & Qasem, H. (2021). Evaluation of e-health (Seha) application: a cross-sectional study in Saudi Arabia. BMC Medical Informatics and Decision Making, 21(1). https://doi.org/10.1186/s12911-021-01437-6
11. Alharbi, N., AlGhanmi, A. S., & Fahlevi, M. (2022). Public awareness, uses, and acceptance towards government health mobile apps during the COVID-19 lockdown: the case of Saudi Arabia. ICIC Express Lett. Part B Appl, 13(9), 887–895. https://doi.org/10.24507/icicelb.13.09.887
12. Ali, G. S., Ozdemir, B., & Selamoglu, Z. (2021). A Review of Severe Acute Respiratory Syndrome Coronavirus 2 and Pathological Disorders in Patients. Journal of Pharmaceutical Care. https://doi.org/10.18502/jpc.v9i3.7373
13. Alkhalifah, J. M., Seddiq, W., Alshehri, B. F., et al. (2022). The role of the COVID-19 pandemic in expediting digital health-care transformation: Saudi Arabia’s experience. Informatics in Medicine Unlocked, 33, 101097. https://doi.org/10.1016/j.imu.2022.101097
14. Almaghaslah, D., Alsayari, A., Almaghaslah, S., et al. (2022). Patients’ Satisfaction with E-Prescribing (Wasfaty) in Saudi Arabia: A Survey of Country-Level Implementation. Healthcare, 10(5), 806. https://doi.org/10.3390/healthcare10050806
15. Al-Otaiby, M., Krissaane, I., Al Seraihi, A., et al. (2022). SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study. International Journal of Infectious Diseases, 122, 758–766. https://doi.org/10.1016/j.ijid.2022.07.025
16. Altamimi, A., & Ahmed, A. E. (2020). Climate factors and incidence of Middle East respiratory syndrome coronavirus. Journal of Infection and Public Health, 13(5), 704–708. https://doi.org/10.1016/j.jiph.2019.11.011
17. Alyami, H. S., Naser, A. Y., Dahmash, E. Z., et al. (2021). Depression and anxiety during the COVID‐19 pandemic in Saudi Arabia: A cross‐sectional study. International Journal of Clinical Practice, 75(7). https://doi.org/10.1111/ijcp.14244
18. Al-Zalfawi, S. M., Rabbani, S. I., Asdaq, S. M. B., et al. (2021). Public Knowledge, Attitude, and Perception towards COVID-19 Vaccination in Saudi Arabia. International Journal of Environmental Research and Public Health, 18(19), 10081. https://doi.org/10.3390/ijerph181910081
19. Amamou, M., & Ben-Ahmed, K. (2023). Managing the COVID-19 pandemic in thirty-two policy measures in Saudi Arabia: A mixed-methods analysis. Journal of Infection and Public Health, 16(10), 1650–1658. https://doi.org/10.1016/j.jiph.2023.08.008
20. Arora, R., Bansal, V., Buckchash, H., et al. (2021). AI-based diagnosis of COVID-19 patients using X-ray scans with stochastic ensemble of CNNs. Physical and Engineering Sciences in Medicine, 44(4), 1257–1271. https://doi.org/10.1007/s13246-021-01060-9
21. Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., et al. (2020). COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. Journal of Clinical Medicine, 9(6), 1753. https://doi.org/10.3390/jcm9061753
22. Bazaid, A. S., Aldarhami, A., Binsaleh, N. K., et al. (2020). Knowledge and practice of personal protective measures during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia. PLOS ONE, 15(12), e0243695. https://doi.org/10.1371/journal.pone.0243695
23. Çalıca Utku, A., Budak, G., Karabay, O., et al. (2020). Main symptoms in patients presenting in the COVID-19 period. Scottish Medical Journal, 65(4), 127–132. https://doi.org/10.1177/0036933020949253
24. Carraturo, F., Del Giudice, C., Morelli, M., et al. (2020). Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces. Environmental Pollution, 265, 115010. https://doi.org/10.1016/j.envpol.2020.115010
25. Chau, C. H., Strope, J. D., & Figg, W. D. (2020). COVID‐19 Clinical Diagnostics and Testing Technology. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 40(8), 857–868. https://doi.org/10.1002/phar.2439
26. Chen, X., Kang, Y., Luo, J., et al. (2021). Next-Generation Sequencing Reveals the Progression of COVID-19. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.632490
27. Chmielewski, D., Wilson, E. A., Pintilie, G., et al. (2023). Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-42836-9
28. Churruca, M., Martínez-Besteiro, E., Couñago, F., et al. (2021). COVID-19 pneumonia: A review of typical radiological characteristics. World Journal of Radiology, 13(10), 327–343. https://doi.org/10.4329/wjr.v13.i10.327
29. Cui, Y., Ni, S., & Shen, S. (2021). A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic. BMC Infectious Diseases, 21(1). https://doi.org/10.1186/s12879-020-05750-9
30. Dx, N. (2021). Noor DX launches new KAUST-developed COVID-19 test kit. Available online: https://innovation.kaust.edu.sa/noor-dx-launches-kaust-COVID-test-kit/ (accessed on 13 June 2024).
31. Experience, T. K. O. S. A. (2020). The kingdom of Saudi Arabia’s experience. Available online: https://www.moh.gov.sa/en/Ministry/MediaCenter/Publications/Documents/COVID-19-NATIONAL.pdf (accessed on 13 June 2024).
32. Fagbo, S. F., Garbati, M. A., Hasan, R., et al. (2016). Acute viral respiratory infections among children in MERS‐endemic Riyadh, Saudi Arabia, 2012–2013. Journal of Medical Virology, 89(2), 195–201. https://doi.org/10.1002/jmv.24632
33. Fancy, N. (2022). Knowing the Signs of Disease: Plague in the Arabic Medical Commentaries between the First and Second Pandemics. Death and Disease in the Medieval and Early Modern World, 35–66. https://doi.org/10.1017/9781800107861.002
34. Hajeer, A., Jawdat, D., Massadeh, S., et al. (2022). Association of KIR gene polymorphisms with COVID-19 disease. Clinical Immunology, 234, 108911. https://doi.org/10.1016/j.clim.2021.108911
35. Hashemi Shahraki, A., Carniel, E., & Mostafavi, E. (2016). Plague in Iran: its history and current status. Epidemiology and Health, 38, e2016033. https://doi.org/10.4178/epih.e2016033
36. Hermens, J. M., & Kesmir, C. (2023). Role of T cells in severe COVID-19 disease, protection, and long term immunity. Immunogenetics, 75(3), 295–307. https://doi.org/10.1007/s00251-023-01294-9
37. Hershan, A. A. (2021). Awareness of COVID-19, Protective Measures and Attitude Towards Vaccination among University of Jeddah Health Field Community: A Questionnaire-Based Study. Journal of Pure and Applied Microbiology, 15(2), 604–612. https://doi.org/10.22207/jpam.15.2.02
38. Hidayat-ur-Rehman, I., Ahmad, A., Ahmed, M., et al. (2021). Mobile Applications to Fight against COVID-19 Pandemic: The Case of Saudi Arabia. TEM Journal, 69–77. https://doi.org/10.18421/tem101-09
39. Hindson, J. (2020). COVID-19: faecal-oral transmission? Nature Reviews Gastroenterology and Hepatology, 17(5), 259–259. https://doi.org/10.1038/s41575-020-0295-7
40. Hsieh, W.Y., Lin, C.H., Lin, T.C., et al. (2021). Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies. Diagnostics, 11(10), 1760. https://doi.org/10.3390/diagnostics11101760
41. Ibeh, I., Enitan, S., Akele, R., et al. (2020). A Review of the COVID-19 Pandemic and the Role of Medical Laboratory Scientists in containment. J Med Lab Sci, 30(1), 68-89.
42. Jabłońska, K., Aballéa, S., & Toumi, M. (2021). The real-life impact of vaccination on COVID-19 mortality in Europe and Israel. Public Health, 198, 230–237. https://doi.org/10.1016/j.puhe.2021.07.037
43. Jackson, B., Boni, M. F., Bull, M. J., et al. (2021). Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic. Cell, 184(20), 5179-5188.e8. https://doi.org/10.1016/j.cell.2021.08.014
44. Jain, S., Jónasson, J. O., Pauphilet, J., et al. (2024). Robust Combination Testing: Methods and Application to COVID-19 Detection. Management Science, 70(4), 2661–2681. https://doi.org/10.1287/mnsc.2023.4826
45. Jaziri, R., Alnahdi, S. (2020). Choosing which COVID-19 patient to save? The ethical triage and rationing dilemma. Ethics, Medicine and Public Health, 15, 100570. https://doi.org/10.1016/j.jemep.2020.100570
46. Johns Hopkins University Medicine. (2023). Available online: https://coronavirus.jhu.edu/region/saudi-arabia (accessed on 13 June 2024).
47. Juneau, C. E., Briand, A. S., Collazzo, P., et al. (2023). Effective contact tracing for COVID-19: A systematic review. Global Epidemiology, 5, 100103. https://doi.org/10.1016/j.gloepi.2023.100103
48. Kang, T., Lu, J., Yu, T., et al. (2022). Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example. Biosensors and Bioelectronics, 206, 114109. https://doi.org/10.1016/j.bios.2022.114109
49. Kashani-Sabet, F. (1998). “City of the Dead”: The Frontier Polemics of Quarantines in the Ottoman Empire and Iran. Comparative Studies of South Asia, Africa and the Middle East, 18(2), 51–58. https://doi.org/10.1215/1089201x-18-2-51
50. Khalifa, A. M., Alshammari, A. F., Alrimali, A. M., et al. (2021). Willingness to Test for COVID-19: A Cross-Sectional Study on the Population in the Ha’il Region, KSA. Journal of Pharmaceutical Research International, 44–53. https://doi.org/10.9734/jpri/2021/v33i1331265
51. Khan, A., Alsofayan, Y., Alahmari, A., et al. (2021). COVID-19 in Saudi Arabia: the national health response. Eastern Mediterranean Health Journal, 27(11), 1114–1124. https://doi.org/10.26719/emhj.21.048
52. Krynytska, I., Marushchak, M., Birchenko, I., et al. (2021). COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review). Iranian Journal of Microbiology. https://doi.org/10.18502/ijm.v13i6.8072
53. Kubina, R., & Dziedzic, A. (2020). Molecular and Serological Tests for COVID-19 A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics. Diagnostics, 10(6), 434. https://doi.org/10.3390/diagnostics10060434
54. Kumar Das, D., Khatua, A., Kar, T. K., et al. (2021). The effectiveness of contact tracing in mitigating COVID-19 outbreak: A model-based analysis in the context of India. Applied Mathematics and Computation, 404, 126207. https://doi.org/10.1016/j.amc.2021.126207
55. Kumar, R., Srivastava, Y., Muthuramalingam, P., et al. (2023). Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review and Meta-Analysis. Viruses, 15(4), 856. https://doi.org/10.3390/v15040856
56. Kwiatkowska, A., & Granicka, L. (2023). Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses. Membranes, 13(5), 464. https://doi.org/10.3390/membranes13050464
57. Li, C., He, Q., Qian, H., et al. (2021). Overview of the pathogenesis of COVID-19 (Review). Experimental and Therapeutic Medicine, 22(3). https://doi.org/10.3892/etm.2021.10444
58. Liebig, J., Najeebullah, K., Jurdak, R., et al. (2021). Should international borders re-open? The impact of travel restrictions on COVID-19 importation risk. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-11616-9
59. Liu, X., Liu, C., Liu, G., et al. (2020). COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics, 10(17), 7821–7835. https://doi.org/10.7150/thno.47987
60. Low, M. C. (2008). Empire and the hajj: pilgrims, plagues, and pan-islam under British surveillance, 1865–1908. International Journal of Middle East Studies, 40(2), 269–290. https://doi.org/10.1017/s0020743808080549
61. Mason, R. J. (2020). Pathogenesis of COVID-19 from a cell biology perspective. European Respiratory Journal, 55(4), 2000607. https://doi.org/10.1183/13993003.00607-2020
62. Naseer, S., Khalid, S., Parveen, S., et al. (2023). COVID-19 outbreak: Impact on global economy. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.1009393
63. Olimat, M. S. (2022). The greater Middle East Covid-19 crisis management: Challenges and opportunities. Journal of International Women’s Studies, 23(3).
64. Pronker, M. F., Creutznacher, R., Drulyte, I., et al. (2023). Sialoglycan binding triggers spike opening in a human coronavirus. Nature, 624(7990), 201–206. https://doi.org/10.1038/s41586-023-06599-z
65. Public Health Authority. (2021). Coronavirus Disease, COVID-19 GUIDELINES. Available online: https://COVID19.cdc.gov.sa/wp-content/uploads/2023/04/V3.1COVID-19-Coronavirus-Disease-Guidelinesfinal-editionApr4-en.pdf (accessed on 13 June 2024).
66. Roff, W. R. (2017). Sanitation and security: the imperial powers and the nineteenth century Hajj. In: The Rise and Fall of Modern Empires. Routledge. pp. 365-382.
67. Saeed, S., Rodríguez Bolívar, M. P., & Thurasamy, R. (editors). (2021). In: Pandemic, Lockdown, and Digital Transformation. Public Administration and Information Technology. Springer International Publishing. https://doi.org/10.1007/978-3-030-86274-9
68. Salam, A. A., Al-Khraif, R. M., & Elsegaey, I. (2022). COVID-19 in Saudi Arabia: An Overview. Frontiers in Public Health, 9. https://doi.org/10.3389/fpubh.2021.736942
69. Santos-Mendoza, T. (2023). The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target. Viruses, 15(4), 1000. https://doi.org/10.3390/v15041000
70. Shafaghi, A. H., Rokhsar Talabazar, F., Koşar, A., et al. (2020). On the Effect of the Respiratory Droplet Generation Condition on COVID-19 Transmission. Fluids, 5(3), 113. https://doi.org/10.3390/fluids5030113
71. Sheerah, H. A., Almuzaini, Y., & Khan, A. (2023). Public Health Challenges in Saudi Arabia during the COVID-19 Pandemic: A Literature Review. Healthcare, 11(12), 1757. https://doi.org/10.3390/healthcare11121757
72. Škare, M., Soriano, D. R., & Porada-Rochoń, M. (2021). Impact of COVID-19 on the travel and tourism industry. Technological Forecasting and Social Change, 163, 120469. https://doi.org/10.1016/j.techfore.2020.120469
73. Spadafora, F. (2023). U.S. Unemployment insurance through the Covid-19 crisis. Journal of Government and Economics, 9, 100069. https://doi.org/10.1016/j.jge.2023.100069
74. Sun, Z., Zhang, H., Yang, Y., et al. (2020). Impacts of geographic factors and population density on the COVID-19 spreading under the lockdown policies of China. Science of The Total Environment, 746, 141347. https://doi.org/10.1016/j.scitotenv.2020.141347
75. Tassinari, A., Panarello, D., Tassinari, G., et al. (2024). Business, as usual? The impact of organized economic interests on the stringency of Covid-19 containment policies: insights from the Italian case. Socio-Economic Review. https://doi.org/10.1093/ser/mwae013
76. Teng, F., Li, J., Cui, T., et al. (2019). Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds. Genome Biology, 20(1). https://doi.org/10.1186/s13059-019-1620-8
77. Tobaiqy, M., Qashqary, M., Al-Dahery, S., et al. (2020). Therapeutic management of patients with COVID-19: a systematic review. Infection Prevention in Practice, 2(3), 100061. https://doi.org/10.1016/j.infpip.2020.100061
78. Uchejeso, O. M., Rinpan, J. I., Chongs, M. E., & Ekpere-Ezeugwu, M. O. (2021). Fighting COVID-19: The Medical Laboratory Involvement. Fighting the COVID-19 Pandemic. https://doi.org/10.5772/intechopen.99459
79. Wang, Y., Deng, Z., & Shi, D. (2021). How effective is a mask in preventing COVID‐19 infection? Medical Devices and Sensors, 4(1). https://doi.org/10.1002/mds3.10163
80. Wells, C. R., Townsend, J. P., Pandey, A., et al. (2021). Optimal COVID-19 quarantine and testing strategies. Nature Communications, 12(1). https://doi.org/10.1038/s41467-020-20742-8
81. Wolszczak-Biedrzycka, B., Bieńkowska, A., & Maksymowicz, S. (2022). Adaptation of medical laboratory scientists to workplace hazards—experiences from the COVID-19 pandemic. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.997049
82. Wu, J. T., Leung, K., Bushman, M., et al. (2020). Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine, 26(4), 506–510. https://doi.org/10.1038/s41591-020-0822-7
83. Wu, W., Cheng, Y., Zhou, H., et al. (2023). The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virology Journal, 20(1). https://doi.org/10.1186/s12985-023-01968-6
84. Xiang, X., Qian, K., Zhang, Z., et al. (2020). CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia. Journal of Drug Targeting, 28(7–8), 727–731. https://doi.org/10.1080/1061186x.2020.1769637
85. Yang, L., Liu, S., Liu, J., et al. (2020). COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction and Targeted Therapy, 5(1). https://doi.org/10.1038/s41392-020-00243-2
86. Zuin, M., Rigatelli, G., Battisti, V., et al. (2023). Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis. International Journal of Cardiology, 372, 138–143. https://doi.org/10.1016/j.ijcard.2022.12.032